Nest.Bio Ventures is a venture capital and private equity firm investing in life science companies that is headquartered in Boston, Massachusetts and was founded in 2016 by Cheryl Cui, Hingge Hsu, James Weis, and Daphene Teo.
Notable investments made by Nest.Bio Ventures include: Engine Biosciences, HiFiBio Therapeutics, ResTORbio, and Root Path.
Nest.Bio Labs is a business accelerator with over 40,000 square feet of laboratory and office space in the United States and Singapore for incubating biotechnology companies. Lab equipment available at Nest.Bio Labs include: thermocycler, qRT-PCR, plate washer and reader, light and UV microscopes, imaging stations, water purification systems, fume hoods, autoclaves, a cell culture room with biosafety cabinets and incubators, centrifuge, bottle wash, water baths, fridges, freezers, ice machines, and vacuum and nitrogen supplies at every lab bench.
Notable graduates and residents of Nest.Bio Labs are Beam Therapeutics, BioBot Analytics, Act Nano, Mother Dirt, Platelet Biogenesis, HiFiBio Therapeutics, Savran Technologies Inc., CuraCloud, Phast, FOUNT Bio, Glydebio, and Geode Therapetuics.
Senti Biosciences is a synthetic biology company.
A biotechnology company in Massachusetts that focuses on developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.
A biopharmaceutical company developing therapeutics for treating age-related diseases.
Engine Biosciences is a San Francisco-based AI company that is focused on drugs development.
Hifibio - High Fidelity Biology is a Paris-based company founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol.
RootPath is a biotechnology company that builds powerful personalized T cell therapy platform.